Panacea Life Sciences Holdings, Inc. (PLSH)
- Previous Close
0.1384 - Open
0.1500 - Bid --
- Ask --
- Day's Range
0.1500 - 0.1900 - 52 Week Range
0.0960 - 0.6250 - Volume
858 - Avg. Volume
4,950 - Market Cap (intraday)
3.353M - Beta (5Y Monthly) 3.32
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4800 - Earnings Date May 10, 2024 - May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Panacea Life Sciences Holdings, Inc., operates as a holding company, manufactures, research, and produces hemp-derived cannabinoid, functional mushroom, kratom, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies for aspect of life under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand name. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.
www.panacealife.com40
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PLSH
Performance Overview: PLSH
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PLSH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PLSH
Valuation Measures
Market Cap
3.35M
Enterprise Value
24.88M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.32
Price/Book (mrq)
--
Enterprise Value/Revenue
10.43
Enterprise Value/EBITDA
-5.24
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-18.50%
Return on Equity (ttm)
--
Revenue (ttm)
2.38M
Net Income Avi to Common (ttm)
-8.02M
Diluted EPS (ttm)
-0.4800
Balance Sheet and Cash Flow
Total Cash (mrq)
115.86k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-61.83k
Company Insights: PLSH
PLSH does not have Company Insights